retatrutide mechanism glp-1 gip glucagon triple agonist review 2024 2025 From Obesity to Metabolic Health: Why Is a Game-Changer Frontiers | Mechanisms of action

It demonstrates that the GLP-1 receptor's activation pathway is "convergent" rather than "pathway-specific": multiple distinct binding events at the extracellular surface can trigger the same conformational rearrangement at the intracellular surface

The drug also causes food to linger in the stomach, which prolongs the feeling of fullness

Retatrutide is not yet FDA-approved, so direct comparison in real-world use is not yet possible

Holst, rskov, Vagn Nielsen, Schwartz)

Garvey, W

Iron and Calcium Supplements Risk: poor absorption and potential GI side effects Choose well-absorbed forms and avoid taking with antacids or thyroid meds